Related references
Note: Only part of the references are listed.Excessive Hepatomegaly of Mice with Hepatocyte-Targeted Elimination of Integrin Linked Kinase Following Treatment with 1,4-Bis [2-(3,5-Dichaloropyridyloxy)] Benzene
Shashikiran Donthamsetty et al.
HEPATOLOGY (2011)
Liver Regeneration after Partial Hepatectomy Critical Analysis of Mechanistic Dilemmas
George K. Michalopoulos
AMERICAN JOURNAL OF PATHOLOGY (2010)
RUNX3 directly interacts with intracellular domain of Notch1 and suppresses Notch signaling in hepatocellular carcinoma cells
Juan Gao et al.
EXPERIMENTAL CELL RESEARCH (2010)
Suppression of Liver Regeneration and Hepatocyte Proliferation in Hepatocyte-Targeted Glypican 3 Transgenic Mice
Bowen Liu et al.
HEPATOLOGY (2010)
Liver-Specific Ablation of Integrin-Linked Kinase in Mice Results in Enhanced and Prolonged Cell Proliferation and Hepatomegaly after Phenobarbital Administration
Shashikiran Donthamsetty et al.
TOXICOLOGICAL SCIENCES (2010)
Investigation of the Role of Glypican 3 in Liver Regeneration and Hepatocyte Proliferation
Bowen Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Enhanced Liver Regeneration Following Changes Induced by Hepatocyte-Specific Genetic Ablation of Integrin-Linked Kinase
Udayan Apte et al.
HEPATOLOGY (2009)
Time-course comparison of xenobiotic activators of CAR and PPAR alpha in mouse liver
Pamela K. Ross et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Distinct proliferative and transcriptional effects of the D-type cyclins in vivo
Lisa K. Mullany et al.
CELL CYCLE (2008)
The Hippo-YAP pathway: new connections between regulation of organ size and cancer
Bin Zhao et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
c-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia
William E. Blanco-Bose et al.
HEPATOLOGY (2008)
Liver regeneration
George K. Michalopoulos
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Filling out the Hippo pathway
Leslie J. Saucedo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells
Petar N. Grozdanov et al.
LABORATORY INVESTIGATION (2006)
Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas
Jian-Hua Luo et al.
HEPATOLOGY (2006)
CAR, the continuously advancing receptor, in drug metabolism and disease
M Qatanani et al.
CURRENT DRUG METABOLISM (2005)
Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration
C Köhler et al.
HEPATOLOGY (2004)
A common set of immediate-early response genes in liver regeneration and hyperplasia
J Locker et al.
HEPATOLOGY (2003)
Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
M Capurro et al.
GASTROENTEROLOGY (2003)
Glypicans
LÅ Fransson
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
The role of glypicans in mammalian development
HH Song et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Peroxisome proliferator-activated receptor-α-/- mice show enhanced hepatocyte proliferation in response to the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene, a ligand of constitutive androstane receptor
A Columbano et al.
HEPATOLOGY (2001)
Glypicans in growth control and cancer
J Filmus
GLYCOBIOLOGY (2001)
The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
P Wei et al.
NATURE (2000)
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene
GM Ledda-Columbano et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
